Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-hydroxy-4-phosphonobutanamide is a small molecule compound with the molecular formula C₄H₁₀NO₅P and a molecular weight of approximately 183.1 g/mol[1][2][6]. It is also known by synonyms such as 4PB, 4PBH, and N-hydroxy-4-phosphono-butanamide. The compound is classified as experimental and does not have an established therapeutic use or approved indication in humans. Its mechanism of action, pharmacological activity, clinical applications, developer information, and manufacturing details are not available in public drug databases[1][2][3]. The structure features a phosphonic acid group attached to a butanamide backbone with an N-hydroxy substituent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-hydroxy-4-phosphonobutanamide.